As of April 16, 2025, Avidity Biosciences (RNA) has a market cap of $3.21 billion USD. According to our data, Avidity Biosciences is ranked No.3257 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $3.21 B |
-7.56%
|
Dec 31, 2024 | $3.47 B |
221.33%
|
Dec 29, 2023 | $1.08 B |
-59.22%
|
Dec 30, 2022 | $2.65 B |
-6.65%
|
Dec 31, 2021 | $2.84 B |
-6.86%
|
Dec 31, 2020 | $3.04 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Wave Life Sciences
WVE
|
$0.96 B |
-0.000 M
|
![]() Singapore
|
![]() Dynavax Technologies
DVAX
|
$1.42 B |
-0.000 M
|
![]() USA
|
![]() Arrowhead Pharmaceuticals
ARWR
|
$1.77 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
Market Cap | = | RNA Stock Price | * | RNA Shares Outstanding |
= | $26.68 | * | 0.12 B | |
= | $3.21 B |